The speed of lead candidate selection studies requires an equally rapid analytical tool to efficiently measure drug concentrations in the biological samples collected. Charles River offers non-GLP discovery bioanalytical services either in support of studies conducted in-house or as a stand-alone service with the flexibility and speed to meet the timelines and diverse needs for discovering the best drug candidate.
Our research-grade assay approach via LC-MS/MS can quickly analyze samples for compound ranking. Once a lead candidate has been selected in the discovery analytical process, these methods can be transferred to method development for GLP bioanalytical testing including feasibility, validation and preclinical and clinical sample analysis.
For more information about our discovery bioanalysis services, please contact us at firstname.lastname@example.org.
Discovery, Preclinical & Clinical Bioanalysis Datasheet